Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aggregate-selective removal of pathological tau by clustering-activated degraders
Jonathan Benn, Shi Cheng, Sophie Keeling, et al.
Science (2024) Vol. 385, Iss. 6712, pp. 1009-1016
Closed Access | Times Cited: 13

Showing 13 citing articles:

Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Lisha Wang, Sooram Banesh, Rajnish Kumar, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Genetically-encoded targeted protein degradation technology to remove endogenous condensation-prone proteins and improve crop performance
Ming Luo, Sitao Zhu, Hua Dang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Organic solvents and neurodegenerative diseases: Exploring a possible link
Mary Beth Genter
Advances in neurotoxicology (2025)
Closed Access
Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6
Shuai Zhao, Jingwen Luo, Pingping Xu, et al.
International Journal of Biological Macromolecules (2025), pp. 142667-142667
Closed Access
Inhibition of tau neuronal internalization using anti-tau single domain antibodies
Clément Danis, Elian Dupré, Thomas Bouillet, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities
Ruixin Ge, Miao Chen, Qingchao Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
A No-Brainer! The Therapeutic Potential of TRIM Proteins in Viral and Central Nervous System Diseases
Adam Hage, Marianne Janes, Sonja M. Best
Viruses (2025) Vol. 17, Iss. 4, pp. 562-562
Open Access
Targeted Protein Degradation: From Basic Science to Therapeutic Applications
R Zhu, Xiaoyu Tang, Heng Zhang
ACS Chemical Biology (2025)
Closed Access
Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond
Carl Alexander Sandhof, Helen C. Murray, M. Catarina Silva, et al.
Neurotherapeutics (2024), pp. e00499-e00499
Closed Access | Times Cited: 2
Targeted degradation of endogenous condensation-prone proteins improves crop performance
Ming Luo, Qing Wen, Sitao Zhu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Downregulation of astrocytic C3 production alleviates neuronal mitochondrial dysfunction in tauopathy models
Chenxu Lei, Bocheng Zhang, Junji Yamaguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
散发性早发型阿尔茨海默病：独特特征、关键机制与未来展望
Zhentao Zhang
Chinese Science Bulletin (Chinese Version) (2024) Vol. 70, Iss. 1, pp. 6-7
Closed Access
Page 1

Scroll to top